IFA Talk is our flagship podcast, that fits perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.
IFA Talk Podcast – listen to the latest episode
Trending Articles
-
Employers see the writing on the wall for pensions salary sacrifice schemes
Over 90% of employers think that the chancellor will place restrictions on pensions salary sacrifice schemes at the upco…
-
Estate planning should be a family-wide conversation: are unused pensions the catalyst many needed to start the process?
Written by Caroline Foulger, Partner at Hunters Law LLP Inheritance Tax has never been straightforward, yet many refer…
-
How long does it really take to save for a house deposit in the UK?
New industry data has revealed that the number of low-deposit mortgages available have risen to their highest level sinc…
-
No-fault evictions: what advisers need to know | Guest insight from Cordelia Smith, Hunters Law LLP
Exclusives, Mortgage and Property
As the Renters’ Rights Bill edges closer to implementation, mortgage advisers should be aware of its ripple effects acro…
-
AJ Bell: State pension set for 4.7% inflation-busting rise as July earnings raise questions over triple lock sustainability
UK state pensions set for boost as latest ONS figures show 4.7% earnings growth, with the triple lock likely to lift the…
-
UK GDP stalls in July raising questions for advisers ahead of Autumn Budget | Industry experts share their analysis
Data released from the ONS today has indicated that monthly GDP growth ground to a halt, after a promising 0.4% rise in…
-
Reframe Cancer enhances cancer product with Pulse to include CQC regulated cancer screening
Reframe Cancer, the leading provider of specialist cancer navigation has enhanced its cancer product for Pulse Insurance…
-
Hargreaves Lansdown: Inflation may rise while interest rates remain on hold
With plenty of key economic data coming through on the UK economy next week, market watchers – including the team at Har…
-
Barclays: UK’s investment gap swells to over £610 billion
New data and analysis from Barclays reveals that the UK’s investment gap grew by over 30 per cent between 2022 and 2024…
-
Here we go again – pre-budget insights from IFGL Pensions’ Steve Berridge
As speculation swirls ahead of the November Budget, with pensions once again appearing to be in the Chancellor’s crossha…
Exclusives
Latest Publications
Explore our latest reports, magazines and special supplements
More Latest News
-
FTSE 100 movers: Miners bounce back; HSBC goes ex-div
London’s FTSE 100 was up 0.1% at 6,732.79 in afternoon trade on Thursday. Paddy Power Betfair owner Flutter Entertainment was the top…
-
Talks between Hikma and GlaxoSmithKline fail to secure a deal
Talks between Hikma Pharmaceutical and drugs giant GlaxoSmithKline have ended, the generics group confirmed on Thursday. Hikma was in discussions to acquire…
-
James Fisher swings to loss, lowers FY dividends
Marine engineer James Fisher swung to a full-year loss in 2020, leading the group to slash its annual dividend. James Fisher said…
-
Glencore chairman Tony Hayward to step down
Glencore is looking for a new chairman after Tony Hayward said he would leave in 2022 after more than eight years in…
-
Fisher James swings to loss, lowers FY dividends
Marine engineer James Fisher swung to a full-year loss in 2020, leading the group to slash its annual dividend. James Fisher said…
-
BAT to invest £126m in Organigram as it expands ‘beyond nicotine’
British American Tobacco said on Thursday that it will invest around £126m for a 19.9% stake in Canada’s Organigram, a company focused…
-
Berenberg lowers IWG from ‘buy’ to ‘hold’
Analysts at Berenberg cut their rating on serviced offices provider IWG from ‘buy’ to ‘hold’ on Thursday, stating they were “pausing for…
-
Profits shine at Gem on higher diamond prices
Specialist producer Gem Diamonds reported improved annual profits on Thursday, after prices strengthened in the second half. The London-listed firm, which owns…
-
Glaxo, Vir stop Covid trial early after drug shows 85% efficacy
Drug companies GlaxoSmithKline and Vir Biotechnology have been advised to finish a final trial of their Covid-19 drug early due to its…
-
Renewi upgrades earnings forecasts, shares jump
Renewi expects full-year earnings to be “significantly” ahead of forecasts, the recycling specialist said on Thursday, boosting the shares. London-listed Renewi, which…